- Home
- MOVE vs SONN Comparison
MOVE vs SONN Comparison
Compare MOVE & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOVE
- SONN
- Stock Information
- Founded
- MOVE 2018
- SONN N/A
- Country
- MOVE United States
- SONN United States
- Employees
- MOVE N/A
- SONN N/A
- Industry
- MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- MOVE Health Care
- SONN Health Care
- Exchange
- MOVE Nasdaq
- SONN Nasdaq
- Market Cap
- MOVE 4.2M
- SONN 3.8M
- IPO Year
- MOVE 2021
- SONN N/A
- Fundamental
- Price
- MOVE $0.65
- SONN $1.25
- Analyst Decision
- MOVE Buy
- SONN Strong Buy
- Analyst Count
- MOVE 1
- SONN 1
- Target Price
- MOVE $30.00
- SONN $20.00
- AVG Volume (30 Days)
- MOVE 994.9K
- SONN 39.3K
- Earning Date
- MOVE 06-17-2025
- SONN 05-13-2025
- Dividend Yield
- MOVE N/A
- SONN N/A
- EPS Growth
- MOVE N/A
- SONN N/A
- EPS
- MOVE N/A
- SONN N/A
- Revenue
- MOVE $1,013,000.00
- SONN $1,000,000.00
- Revenue This Year
- MOVE $1,460.71
- SONN $5,376.22
- Revenue Next Year
- MOVE $96.77
- SONN N/A
- P/E Ratio
- MOVE N/A
- SONN N/A
- Revenue Growth
- MOVE N/A
- SONN 978.39
- 52 Week Low
- MOVE $0.51
- SONN $1.08
- 52 Week High
- MOVE $6.97
- SONN $16.00
- Technical
- Relative Strength Index (RSI)
- MOVE 40.68
- SONN 51.70
- Support Level
- MOVE $0.61
- SONN $1.13
- Resistance Level
- MOVE $0.68
- SONN $1.21
- Average True Range (ATR)
- MOVE 0.12
- SONN 0.08
- MACD
- MOVE 0.02
- SONN 0.00
- Stochastic Oscillator
- MOVE 17.93
- SONN 56.67
About MOVE Movano Inc.
Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.